| A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. (NCT00502996) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422383) | Hoffmann-La Roche | 2006-02-01 |
| Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan (NCT00944320) | National Chung Hsing University | 2006-02-01 |
| A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement (NCT00698152) | Zimmer Biomet | 2006-01-23 |
| A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate (NCT00282308) | Genentech, Inc. | 2006-01-23 |
| Real-World Emulation of the SWEFOT Trial (NCT05051137) | Karolinska Institutet | 2006-01-12 |
| Intra-articular Glucocorticoid Treatment of the Elbow (NCT00972530) | Region Gävleborg | 2006-01-01 |
| A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis (NCT00299104) | Genentech, Inc. | 2006-01-01 |
| Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) (NCT00254293) | Bristol-Myers Squibb | 2006-01-01 |
| Role of DcR3 in T Cell Activation in SLE and RA (NCT00275899) | National Taiwan University Hospital | 2006-01-01 |
| A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422942) | Hoffmann-La Roche | 2006-01-01 |
| Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) (NCT00724243) | Merck Sharp & Dohme LLC | 2006-01-01 |
| An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis (NCT00346294) | Amgen | 2006-01-01 |
| Predictors of the Response to Adalimumab in Rheumatoid Arthritis (NCT00234234) | University Hospital, Rouen | 2006-01-01 |
| A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate (NCT00266227) | Genentech, Inc. | 2006-01-01 |
| Efferocytosis and Genomic Polymorphism in Autoimmune Diseases (NCT00364728) | National Taiwan University Hospital | 2006-01-01 |
| Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs (NCT03496831) | Simon Krabbe | 2006-01-01 |
| Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) (NCT00264147) | Organon and Co | 2006-01-01 |
| An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00264550) | Centocor, Inc. | 2005-12-01 |
| A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) (NCT00705289) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients (NCT00669942) | Novartis Pharmaceuticals | 2005-12-01 |
| A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive (NCT00264537) | Centocor, Inc. | 2005-12-01 |
| Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis (NCT00285441) | Hvidovre University Hospital | 2005-11-01 |
| Development and Evaluation of A Mailed Arthritis Self-Management Program (NCT00448474) | University of North Carolina | 2005-11-01 |
| A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00160641) | UCB Pharma | 2005-11-01 |
| Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background (NCT00162292) | Bristol-Myers Squibb | 2005-11-01 |
| Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis (NCT00292422) | Biogen | 2005-11-01 |
| A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy (NCT00316771) | Hoffmann-La Roche | 2005-11-01 |
| A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02720120) | Hoffmann-La Roche | 2005-10-01 |
| Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis (NCT00241982) | Radboud University Medical Center | 2005-10-01 |
| A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis (NCT00299130) | Genentech, Inc. | 2005-10-01 |
| Enbrel Liquid Immunogenicity Protocol (NCT00249041) | Amgen | 2005-10-01 |
| Health Outcomes in Rheumatoid Arthritis (NCT00346411) | Johns Hopkins University | 2005-09-01 |
| The Effect of Rituximab on the Humoral Response to Influenza Vaccine (NCT00466037) | Tel-Aviv Sourasky Medical Center | 2005-09-01 |
| An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies (NCT00720798) | Hoffmann-La Roche | 2005-09-01 |
| Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis (NCT00691028) | Tanabe Pharma Corporation | 2005-09-01 |
| Improving Motivation for Physical Activity in Arthritis Clinical Trial (NCT00248105) | Northwestern University | 2005-09-01 |
| Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis (NCT00216177) | Hvidovre University Hospital | 2005-09-01 |
| Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) (NCT00172666) | National Taiwan University Hospital | 2005-08-01 |
| A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis (NCT00721123) | Hoffmann-La Roche | 2005-08-01 |
| Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis (NCT00141830) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| A Clinical Investigation of the Taperloc® Microplasty™ Hip System (NCT00699309) | Biomet Orthopedics, LLC | 2005-08-01 |
| A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate (NCT00243412) | Genentech, Inc. | 2005-08-01 |
| A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. (NCT00141934) | Sosei | 2005-08-01 |
| Remission and Joint Damage Progression in Early Rheumatoid Arthritis (NCT00122382) | Bristol-Myers Squibb | 2005-07-01 |
| A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis (NCT00109408) | Hoffmann-La Roche | 2005-07-01 |
| A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. (NCT00503425) | Hoffmann-La Roche | 2005-06-30 |
| Total Knee Replacement With Duracon® and Vanguard™ Prostheses (NCT00588887) | Biomet Orthopedics, LLC | 2005-06-01 |
| Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis (NCT00233558) | Abbott | 2005-06-01 |
| Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 (NCT00205478) | Vertex Pharmaceuticals Incorporated | 2005-06-01 |
| Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (NCT00688103) | Japan Biological Agent Study Integrated Consortium | 2005-06-01 |
| A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00175877) | UCB Pharma | 2005-06-01 |
| A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00160602) | UCB Pharma | 2005-06-01 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy (NCT00106522) | Hoffmann-La Roche | 2005-05-01 |
| The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study. (NCT01270087) | Skane University Hospital | 2005-05-01 |
| Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis (NCT00432484) | Chinese University of Hong Kong | 2005-05-01 |
| Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW) (NCT00115219) | Amgen | 2005-05-01 |
| Co-Administration Of Methotrexate And CP-690,550 (NCT01745055) | Pfizer | 2005-04-01 |
| Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis. (NCT01307787) | University Medical Center Groningen | 2005-04-01 |
| A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00106574) | Hoffmann-La Roche | 2005-04-01 |
| Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy (NCT00124982) | Bristol-Myers Squibb | 2005-04-01 |
| Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) (NCT01088360) | Bristol-Myers Squibb | 2005-03-31 |
| Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP (NCT00144586) | Chugai Pharmaceutical | 2005-03-01 |
| Safety Study of Abatacept to Treat Rheumatoid Arthritis (A) (NCT01088321) | Bristol-Myers Squibb | 2005-03-01 |
| Rheumatic Diseases and Computer Use (NCT00177320) | University of Pittsburgh | 2005-03-01 |
| Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan (NCT00503503) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-03-01 |
| Treatment of Hypovitaminosis D in Rheumatoid Arthritis (NCT00423358) | University of Wisconsin, Madison | 2005-02-01 |
| Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (NCT00095147) | Bristol-Myers Squibb | 2005-02-01 |
| Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) (NCT00105976) | Merrimack Pharmaceuticals | 2005-02-01 |
| Pain and Stress Management for People With Rheumatoid Arthritis (NCT00088764) | Wayne State University | 2005-02-01 |
| A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis (NCT00152386) | UCB Pharma | 2005-02-01 |
| Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) (NCT00144560) | Chugai Pharmaceutical | 2005-02-01 |
| Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study (NCT00522184) | Centre Hospitalier Universitaire de Nice | 2005-02-01 |
| A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement (NCT00208455) | DePuy International | 2005-02-01 |
| Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment (NCT00144573) | Chugai Pharmaceutical | 2005-01-01 |
| Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks (NCT00147498) | Pfizer | 2005-01-01 |
| A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 (NCT00583557) | Human Genome Sciences Inc. | 2005-01-01 |
| Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women (NCT00110565) | National Center for Complementary and Integrative Health (NCCIH) | 2005-01-01 |
| A Clinical Investigation of the Balance® Microplasty™ Hip System (NCT00699088) | Biomet Orthopedics, LLC | 2005-01-01 |
| A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) (NCT00132769) | Merck Sharp & Dohme LLC | 2005-01-01 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) (NCT00106535) | Hoffmann-La Roche | 2005-01-01 |
| Acupuncture for the Treatment of Rheumatoid Arthritis (NCT00404443) | Chinese University of Hong Kong | 2004-12-01 |
| Reciprocating Medical Devices - a Study of a New Safety Device (NCT00651625) | University of New Mexico | 2004-11-01 |
| A Clinical Investigation of the M2a-Magnum™ Hip System (NCT00698347) | Biomet Orthopedics, LLC | 2004-11-01 |
| Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital (NCT00854321) | Kuopio University Hospital | 2004-11-01 |
| A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications (NCT01600521) | University of Minnesota | 2004-11-01 |
| Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis (NCT00195494) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-11-01 |
| 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis (NCT00170872) | Novartis | 2004-11-01 |
| A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA (NCT00747214) | Zalicus | 2004-11-01 |
| Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes (NCT00094341) | Amgen | 2004-10-01 |
| A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis (NCT00242853) | GlaxoSmithKline | 2004-10-01 |
| A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201 (NCT00831649) | Biogen | 2004-09-01 |
| Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis (NCT00831922) | AB Science | 2004-09-01 |
| A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis (NCT00638950) | University of Jena | 2004-09-01 |
| Tai Chi for Patients With Rheumatoid Arthritis (NCT00522054) | Diakonhjemmet Hospital | 2004-09-01 |
| Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial) (NCT00412256) | Humanis Klinikum Niederosterreich | 2004-09-01 |
| Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis (NCT00146640) | Merck KGaA, Darmstadt, Germany | 2004-08-31 |
| Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis (NCT00095498) | Amgen | 2004-08-11 |
| Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis (NCT00235872) | Abbott | 2004-08-01 |
| Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? (NCT00696059) | Hvidovre University Hospital | 2004-08-01 |